Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the …

M Valgimigli, G Campo, G Percoco, L Bolognese… - Jama, 2008 - jamanetwork.com
Context Abciximab infusion and uncoated-stent implantation is a complementary treatment
strategy to reduce major adverse cardiac events in patients undergoing angioplasty for ST …

Mechanisms of acute brain injury after subarachnoid hemorrhage

FA Sehba, JB Bederson - Neurological research, 2006 - Taylor & Francis
Brain injury after subarachnoid hemorrhage (SAH) is a biphasic event with an acute
ischemic insult at the time of the initial bleed and secondary events such as cerebral …

[HTML][HTML] CD40L and its receptors in atherothrombosis—an update

NA Michel, A Zirlik, D Wolf - Frontiers in cardiovascular medicine, 2017 - frontiersin.org
CD40L (CD154), a member of the tumor necrosis factor superfamily, is a co-stimulatory
molecule that was first discovered on activated T cells. Beyond its fundamental role in …

Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa

DW Bougie, PR Wilker, ED Wuitschick… - Blood, The Journal …, 2002 - ashpublications.org
Acute thrombocytopenia is a recognized complication of treatment with GPIIb/IIIa inhibitors
whose cause is not yet known. We studied 9 patients who developed severe …

Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes

DL Bhatt, EJ Topol - Jama, 2000 - jamanetwork.com
ContextThe central role of platelet-rich thrombus in the pathogenesis of acute coronary
syndromes (ACSs) is well-known. Glycoprotein IIb/IIIa (Gp IIb/IIIa) receptor antagonists are …

Clinical pharmacology of antiplatelet drugs

G Gelbenegger, B Jilma - Expert Review of Clinical Pharmacology, 2022 - Taylor & Francis
Introduction Platelets play a key role in arterial thrombosis and antiplatelet therapy is pivotal
in the treatment of cardiovascular disease. Current antiplatelet drugs target different …

Structural and functional characterization of the mouse von Willebrand factor receptor GPIb-IX with novel monoclonal antibodies

W Bergmeier, K Rackebrandt… - Blood, The Journal …, 2000 - ashpublications.org
Five novel monoclonal antibodies (mAbs; p0p 1-5) were used to characterize the structural
and functional properties and the in vivo expression of the murine GPIb-IX complex (von …

Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy

K Moshfegh, M Redondo, F Julmy… - Journal of the American …, 2000 - jacc.org
OBJECTIVES We sought to compare the inhibitory effects of the combination of two doses of
aspirin plus clopidogrel with either drug alone on platelet aggregation and activation …

Anticoagulant and antiplatelet agents: their clinical and device application (s) together with usages to engineer surfaces

AG Kidane, H Salacinski, A Tiwari… - …, 2004 - ACS Publications
An essential aspect of the treatment of patients with cardiovascular disease is the use of
anticoagulant and antiplatelet agents for the prevention of further ischaemic events and …

[HTML][HTML] Shedding of procoagulant microparticles from unstimulated platelets by integrin-mediated destabilization of actin cytoskeleton

S Cauwenberghs, MAH Feijge, AGS Harper, SO Sage… - FEBS letters, 2006 - Elsevier
Platelet activation by potent, Ca2+-mobilizing agonists results in shedding of microparticles
that are active in coagulation. Here we show that platelets under storage produce …